ID: MRFR/MED/1810-HCR | 95 Pages | Published By Rahul Gotadki on March 2023
Mammography Market size is expected to register a CAGR of 9.25 % and was valued at USD 4.76 Billion.
The mammography market size was valued USD 1.91 billion in 2021 and is expected to reach USD 4.76 billion by 2030 at 9.25% CAGR during the forecast period 2022-2030. A mammography system is a medical imaging device that uses low-dose x-rays to examine the breast's internal structure and diagnose breast cancer. It is a minimally invasive treatment.
Increasing awareness of breast cancer, the need for screening treatment through various government campaigns, awareness from NGOs, etc. As a result, the demand for mammography systems is increasing, driving the market's growth. Breast cancer is widespread in the elderly, and the increasing use of hormone replacement therapy (HRT) increases the need for breast diagnostic solutions worldwide. Breast cancer is diagnosed by mammography, which is considered the gold standard.
Increasing breast cancer epidemics, breast imaging technology development, and investment by various organizations in breast cancer awareness campaigns have all contributed to the rise of the mammography system market. Breast cancer is one of the most common malignancies in women. It is also the third most common cause of Native American cancer deaths. Breast cancer and other breast-related disorders can be easily detected by mammography. Therefore, all these factors are propelling the Mammography Market's growth.
Covid 19 Analysis
The COVID-19 epidemic had a huge influence on Mammography Companies since hospital and healthcare services were drastically decreased owing to social distancing measures implemented by governments throughout the world. Furthermore, the COVID-19 pandemic not only had a significant influence on the global economy, but it also had a significant influence on the functioning of general hospital treatment for non-COVID-19 patients in hospitals across the world. Because many hospitals and screening centers are still closed due to lockdowns, demand for mammography operations is projected to be low in the immediate term.
The increasing prevalence of breast cancer, technical improvements in the area of breast imaging, and investment from various organizations in breast cancer screening programmers are the primary drivers driving the growth of the mammography market.
The increasing attempts by various governments and NGOs to promote awareness regarding early detection of macrocalcifications in breast tissue might be contributed to market expansion. Some significant organizations, such as the National Breast Cancer Foundation, the Centers for Disease Control and Prevention, and the Breast Cancer Organization, are promoting early detection of mammary gland calcification, which is one of the major opportunities expected to drive demand over the forecast period.
The absence of funding mechanisms, societal stigma, and health concerns related to radiation exposure can all stymie worldwide mammography market growth.
The mammography market is expected to have challenges in the next years. There are three major causes behind this, which are as follows: The installed base of digital breast tomosynthesis (DBT) in the United States has begun to saturate, mammography equipment costs pressure is projected to intensify, and interest and growth are projected to be pushed overseas.
Cumulative Growth Analysis
Breast cancer was the most common kind of cancer in 2020, according to a Globocan analysis, with a prevalence incidence of 11.7 percent. According to the same research, Asia had the biggest number of persons impacted at 3,218,496 (41.3 percent), followed by Europe at 2,138,117 (27.4 percent), and North America with 1.189,111 persons (15.3 percent ). Because of the increasing frequency of breast cancer, demand for mammography machines is predicted to rise, since they will be employed for diagnostic purposes.
Furthermore, as the world population ages, a considerable number of women are predicted to reach the 60-plus age bracket. Women over the age of 60 account for about 78 percent of all breast cancer-related fatalities. Breast cancer has a high incidence and fatality rate in this age range, indicating significant unmet demand for breast cancer diagnostics. The need for mammography services is likely to rise as the number of events and fatalities rises. This is still a primary driver for the mammography industry and is projected to fuel growth over the projected period.
Value Chain Analysis
According to the reports, the global mammography market is segmented on the basis of type, technology, product, end-users, and region. The market has been divided into two types: screening mammography and diagnostic mammography. The worldwide mammography market has been divided into three segments based on technology: 2-D technology, 3-D technology, and combination technology. Based on product, the worldwide mammography market is divided into digital systems, analog systems, breast tomosynthesis film-screen systems, and others. The market is divided into hospitals, specialized clinics, research institutions, diagnostic centers, and others based on end-user.
The market is segmented on the basis of the type, technology, product, end-users, and region. The global mammography market is expected to witness decent growth during the forecast period.
Based on the Product, the market is segmented into digital systems, analog systems, breast tomosynthesis film-screen systems, and others.
Based on the propulsion types, the market is segmented into hospitals, specialized clinics, research institutions, diagnostic centers, and others.
According to the reports, on the basis of region, the mammography market has been segmented into four regions: the Americas, Europe, Asia-Pacific, and the Middle East, and Africa. The Americas mammography market has been further subdivided into North America and Latin America, with the North American market segmented into the United States and Canada. The European mammography market is separated into two parts: Western Europe and Eastern Europe. Western Europe's market has been subdivided into the United Kingdom, Italy, Germany, France, Spain, and the rest of Western Europe. The Asia-Pacific mammography market has been divided into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Middle East & Africa mammography market has been separated into two parts: the Middle East and Africa.
Because of the increasing frequency of breast cancers and rising per capita healthcare spending in the area, the mammography market in the Americas is predicted to dominate the global industry. Breast cancer is the greatest cause of mortality in women, according to the World Health Organization (WHO), with over two million new cases diagnosed each year.
Europe's market is expanding at a rapid pace. This is due to the presence of a well-established healthcare system and rising government incentives for the development of innovative treatment alternatives and is expected to present the mammography market share with strong growth potential. The introduction of next-generation 3D mammography technology, for example, has increased the efficiency of breast cancer operations and therapies. The Asia-Pacific market is expected to develop at a steady rate during the forecast period, owing to rising patient awareness of breast cancer and an increase in the number of government efforts for healthcare reform.
Because of the presence of a few significant mammography market manufacturers in the industry, the mammography industry is concentrated. The top market competitors are concentrating on technical breakthroughs and minimizing the adverse effects of treatments.
Major Key Players
The following report comprises of –
In May 2022
Volpara Health unveiled the latest product of an integrated platform for providing personalized breast care at the 2022 SBI / ACR Breast Imaging Symposium. And cancer risk assessment.
In January 2022
ScreenPoint Medical expanded its footprint in the United States and 30 countries worldwide with the launch of Transpara, an AI breast care system.
In November 2020
Hologic Inc. and RadNet partnered to accelerate the development of artificial intelligence breast health products. Data sharing, research and development, and upgrading RadNet's Hologic mammography system to the latest imaging technology may all be part of the agreement.
In May 19, 2021
Philips announced the Spectral Computed Tomography 7500 system, which provides spectral data for each patient and scan.
Global Mammography Market, by Type
Global Mammography Market, by Product
Global Mammography Market, by End User
Global Mammography Market, by Region
|Market Size||USD 4.76 Billion|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Technology, Product, End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||GE Healthcare, Koninklijke Philips NV, Hologic, INC., Gamma Medica, Inc., Konica Minolta Business Solutions India Private Limited, Carestream Health., BMI Biomedical International SRL, Canon Inc. Metaltronica SpA, PLANNED OY, FUJIFILM Holdings Corporation, GENERAL MEDICAL ITALIA, Siemens Healthcare, and Villa Systems Medical SpA|
|Key Market Opportunities||
|Key Market Drivers||
The global mammography market is expected to thrive at a CAGR of 9.25% from 2022 to 2030.
Siemens Healthcare, Hologic, INC., Canon Inc. Metaltronica SpA, BMI Biomedical International SRL, GENERAL MEDICAL ITALIA, PLANNED OY, Gamma Medica, Inc., Koninklijke Philips NV, Villa Systems Medical SpA, FUJIFILM Holdings Corporation, Konica Minolta Business Solutions India Private Limited, Carestream Health, and GE Healthcare are the major players within the global mammography market.
Risk of radiation, social stigma of mammography tests, and unfavorable reimbursement schemes are major challenges of the global mammography market.
The Americas are touted to lead the global mammography market owing to the rising number of breast cancer cases and the large healthcare expenditure allocated for women by nations globally.
Rising number of government campaigns, awareness among women, and rising number of breast cancer cases are the major drivers of the global mammography market.